Abbott to buy Latin American drugmaker CFR Pharma

May 16 (Reuters) - Abbott Laboratories said it would acquire Latin American pharmaceutical company CFR Pharmaceuticals, which would more than double its branded generic drugs portfolio and expand its presence in Latin America.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.